Single-dose Study to Describe the Pharmacodynamics (PD) and Safety of Sarilumab (REGN88/SAR153191) and Tocilizumab in Adults With Rheumatoid Arthritis (RA)

PHASE1CompletedINTERVENTIONAL

Enrollment

105

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions

Rheumatoid Arthritis

Interventions

DRUG

Sarilumab

DRUG

Tocilizumab

Trial Locations (19)

Birmingham

Orange

DeLand

Edgewater

Miami

Miami Lakes

Granger

Grand Blanc

Charlotte

Cinicinnati

Memphis

Austin

Carrollton

Channelview

Dallas

Houston

Mesquite

Plano

San Antonio